Hospital Guide: Zhejiang University Second Affiliated Hospital - Where Innovation Meets Compassion in China's Medical Hub
- Troy Chen
- Jul 24
- 2 min read
Founded in 1869 as Zhejiang’s birthplace of Western medicine, we are China’s first Class III Grade A hospital and a global benchmark for integrated clinical-research-transformation excellence.

🏥 I. Hospital Overview & Global Positioning
Legacy & Scale:
156-year history; G20 Summit & Hangzhou Asian Games core medical support unit.
Multi-campus system:
Binjiang Campus: Advanced tertiary care hub.
Xiaoshan Headquarters (opening 2025): China’s largest new hospital project (2,500 beds, 107 ORs), designed as a "world-class medical-scientific complex".
Accolades:
Top 10 in China’s public hospital performance evaluations (6 consecutive years).
Designated National Medical Center for cardiovascular and critical care innovation.
⚙️ II. Cutting-Edge Medical Capabilities
A. Pioneering Technology Ecosystem
Smart Imaging & Intervention:
CBCT-guided tumor embolization: Achieves sub-lobar precision for liver cancer (e.g., millimeter-level vessel targeting).
AI coronary analysis: Non-invasive FFR calculation replacing pressure wires, reducing costs by 40%.
Real-time 3D ultrasound + intraoperative neurophysiological monitoring for complex valve surgeries.
Robotics & Hybrid ORs:
Da Vinci Xi Surgical System, hybrid angio-suites, and M6 CyberKnife.
B. Global-Leading Specialty Centers
Cardiovascular Center:
Transcatheter Valve Innovations:
Developed China’s first retrievable aortic valve and DragonFly mitral valve repair system
Pioneered "Hangzhou Protocol" for high-risk bicuspid valve cases—adopted in 18 centers across 12 countries (Italy, Turkey, Argentina, etc.).
Landmark Case (July 2025): Guided Turkey’s top hospital in implanting Chinese valves in a 91-year-old with extreme aortic stenosis.
Precision Oncology & Interventional Therapy:
CBCT-guided TACE: Reduced radiation exposure by 30% and contrast-induced kidney injury risk.
Multidisciplinary teams for liver, lung, and neuroendocrine tumors.
Neurovascular & Orthopedic-Robotic Centers:
Xiaoshan HQ to feature dedicated Brain & Heart Centers with AI-operative integration.
🧑⚕️ III. World-Renowned Expert Teams
Prof. Wang Jian'an
Academician, Chinese Academy of Sciences; Director of National Key Lab for Transvascular Implants.
Global ambassador for "China-made valve solutions"; trained surgeons in 12 countries.
Prof. Jiang Jun:
Cardiovascular AI pioneer; developed non-invasive FFR technology.
Prof. Li Qiang :
Leader in CBCT-guided tumor interventions4.
Multidisciplinary Alliances:
70% senior physicians trained at Mayo Clinic, Cleveland Clinic, or European centers.

🌆 IV. Hangzhou: Asia’s Rising Med-Travel Destination
A. Policy & Connectivity Advantages
Visa Facilitation:
240-hour visa-free transit; medical fast-track visas proposed by Academician Wang Jian'an.
Cross-Border Medical Access:
Early adoption of overseas-approved drugs/devices (e.g., FARAPULSE PFA).
B. Integrated Recovery & Culture
Cultural Attractions:
West Lake UNESCO Site (20-min drive from Binjiang Campus).
Lingyin Temple & Grand Canal heritage tours.
✈️ V. International Patient Services & Logistics
A. Dedicated Care Pathway
One-Stop Coordination:
Multilingual case managers (English/Japanese/Arabic).
Fast-tracked appointments via MedTourChina.
Financial & Cultural Support:
Direct billing with AXA/Allianz; Halal/Kosher meals; prayer rooms.
B. Seamless Transit Guide
Binjiang Campus:
Address: 1828 Binsheng Rd, Binjiang District.
From Xiaoshan Airport: Metro Line 7 → Line 6 (45 mins); taxi (30 km, ¥100).
Xiaoshan HQ (Opens Q4 2025):
Address: Shushan Rd & South Fourth Rd, Xiaoshan District.
From Hongqiao (Shanghai): High-speed rail to Hangzhou East (1 hr) → Metro Line 2 (50 mins).



Comments